| Name: | (R)-(3-methyl-1-(pyrazine-2-carboxamido)butyl)boronic acid |
| Catalogue No. | VL1200004 |
| CAS No. | N/A |
| Molecular Formula | C10H16BN3O3 |
| Molecular Weight | 237.07 g/mol |
| Status | In-stock |
| IUPAC Name | (R)-(3-methyl-1-(pyrazine-2-carboxamido)butyl)boronic acid |
| Synonyms | Bortezomib Impurity 7 |
| Description | Bortezomib Impurity E or (R)-(3-methyl-1-(pyrazine-2-carboxamido)butyl)boronic acid is associated impurity of Bortezomib. Bortezomib is employed to treat two forms of blood cancer in adults, multiple myeloma and mantle cell lymphoma (MCL). |
| References | “Sci-Hub | Review of Bortezomib Treatment of Antibody-Mediated Rejection in Renal Transplantation | 10.1089/Ars.2014.5892.” Hkvisa.net, 2014, sci-hub.hkvisa.net/10.1089/ars.2014.5892. |
